This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Nutanix (NTNX) Q3 Loss Narrower Than Estimated, Revenues Miss
by Zacks Equity Research
Nutanix (NTNX) delivers record ACV billings in the third quarter of fiscal 2022, primarily driven by strong demand for its hybrid multi-cloud software solutions.
DXC Technology's (DXC) Q4 Earnings & Revenue Miss Estimates
by Zacks Equity Research
DXC Technology's (DXC) Q4 earnings benefit from margin expansion, lower interest expenses and outstanding common stocks, which more than offset the negative impact of reduced revenues.
New Strong Buy Stocks for May 26th
by Zacks Equity Research
TX, IBEX, AMR, VSH, and ACLS have been added to the Zacks Rank #1 (Strong Buy) List on May 26, 2022.
Intuit's (INTU) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Intuit's (INTU) Q3 results reflect strong improvement in the do-it-yourself category, solid customer growth and robust revenues from the Credit Karma and Mailchimp businesses.
Microchip (MCHP) Launches World's First Single-Core MPU
by Zacks Equity Research
Microchip Technology (MCHP) unveils its new microprocessor unit, which expands its offerings that ensure high performance at a lower consumption rate.
Zoom's (ZM) Q1 Earnings Top Estimates, Revenues Jump Y/Y
by Zacks Equity Research
Zoom's (ZM) first-quarter fiscal 2023 results reflect steady user growth and improved renewal rates.
What's in the Cards for Photronics' (PLAB) Q2 Earnings?
by Zacks Equity Research
Photronics (PLAB) second-quarter results are likely to reflect benefits from expanded capacity in FPD and IC factories and growing demand for legacy semiconductor foundry.
Microchip (MCHP) Aids Portfolio Via New Time Measurement System
by Zacks Equity Research
Microchip Technology (MCHP) unveils its Precise Time Scale System, which extends its offerings as a substitute to address cyber-security issues.
What Makes Axcelis (ACLS) a New Strong Buy Stock
by Zacks Equity Research
Axcelis (ACLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
How Much Upside is Left in Axcelis (ACLS)? Wall Street Analysts Think 47%
by Zacks Equity Research
The mean of analysts' price targets for Axcelis (ACLS) points to a 46.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Palo Alto's (PANW) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Palo Alto Networks' (PANW) Q3 results reflect benefits from solid demand across its cyber security portfolio amid the growing hybrid work trend and cloud migration worldwide.
Microchip (MCHP) Boosts Portfolio With New Securities Platform
by Zacks Equity Research
Microchip Technology (MCHP) announces the launch of its new CEC1736 solution, which extends its offerings to ensure the cyber resiliency of different platforms.
Check Point (CHKP) Releases Harmony Mobile Version 4.0
by Zacks Equity Research
Check Point's (CHKP) latest release of the new version of its Harmony Mobile solution intends to enhance complete mobile security by blocking the download of malicious files across all vectors.
Synopsys' (SNPS) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Synopsys' (SNPS) Q2 results reflect benefits from solid demand for its products amid rapid adoption of Big Data, faster computation and Machine Learning.
3 Reasons Why Growth Investors Shouldn't Overlook Axcelis (ACLS)
by Zacks Equity Research
Axcelis (ACLS) possesses solid growth attributes, which could help it handily outperform the market.
Stratasys (SSYS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Stratasys' (SSYS) Q1 performance reflects growth across all segments and geographies. However, material inflation and rising logistics costs remain a concern.
Mercury (MRCY) Introduces Industry-First AMMP Computer
by Zacks Equity Research
Mercury's (MRCY) latest release of SOSA-aligned Avionics Modular Mission Platform computer intends to enhance decision accuracy and response times for pilots and aircraft, avoiding operational risks.
Stratasys' (SSYS) MakerBot Merges With Netherland's Ultimaker
by Zacks Equity Research
Stratasys' (SSYS) New York-based subsidiary, MakerBot, is set to merge with Netherland's 3D printing company, Ultimaker, to jointly improve additive manufacturing adoption globally.
Nova (NVMI) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Nova's (NVMI) first-quarter 2022 results reflect an expanded partner base and customer growth.
CyberArk's (CYBR) Q1 Loss Matches Estimates, Revenues Miss
by Zacks Equity Research
CyberArk's (CYBR) first-quarter results reflect strong demand for the company's SaaS Solutions and on-premise subscription offerings.
Amdocs (DOX) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Amdocs' (DOX) fiscal second-quarter 2022 results reflect benefits from its core businesses and North America's stellar performance.
Buy These 5 Low-Leverage Stocks Amid Ongoing Market Turmoil
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt as a debt-free stock is almost impossible to find. One may buy stocks like ACLS, VLO, HZO, ZOM & MRO.
Mercury (MRCY), Lockheed Martin Tie Up for Sensor Processing
by Zacks Equity Research
Mercury's (MRCY) latest collaboration with Lockheed Martin will meet mission-critical requirements of the aerospace and defense industry through the development of new sensor processing technologies.
Sabre (SABR) to Acquire Nuvola, Boost Hospitality Portfolio
by Zacks Equity Research
Sabre's (SABR) buyout of cloud-based guest service management software company, Nuvola, will strengthen SABR's position in retailing & operations portfolio and boost its Hospitality Solutions segment.
3D Systems (DDD) Earnings & Revenue Miss Estimates in Q1
by Zacks Equity Research
3D Systems' (DDD) first-quarter 2022 results reflect year-over-year growth and acceleration beyond pre-pandemic levels across Industrial and Healthcare businesses when adjusted for divestments.